What is Natus?
Founded in 1987 and headquartered in Pleasanton, California, Natus Medical Incorporated specializes in providing advanced medical device solutions. The company's core focus lies in the diagnosis and treatment of disorders affecting the central nervous and sensory systems. Natus offers a comprehensive suite of products and services designed for screening, detection, treatment, monitoring, and tracking of various medical conditions across critical care areas, including newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. Its established presence in these specialized healthcare markets highlights its role as a key provider of essential medical technologies.
How much funding has Natus raised?
Natus has raised a total of $55M across 1 funding round:
Stock Offering
$55M
Stock Issuance/Offering (2001): $55M, investors not publicly disclosed
What's next for Natus?
With a history of enterprise-level funding and a recent strategic investment, Natus is well-positioned for continued expansion and innovation in its specialized medical device markets. The company's focus on diagnosis and treatment for complex neurological and sensory conditions suggests ongoing investment in research and development to enhance its product portfolio. Future strategic moves are likely to involve further market penetration, potential acquisitions to broaden its technological capabilities, and continued efforts to address unmet needs in patient care, particularly in newborn and neurological health. The substantial capital infusion indicates confidence from investors in Natus's long-term strategy and its capacity to drive advancements in medical technology.
See full Natus company page
